Written and maintained by CASRAI Editorial Board
Published
This page describes products and general use; it is not medical advice.
On this page
Short answer
The BD Nexiva is an all-in-one closed peripheral IV catheter system pre-assembled with an extension set, stabilization platform, and needle-free connector. Made with BD Vialon polyurethane and BD Instaflash needle technology, it is FDA Class II cleared under 21 CFR 880.5200 to sample blood, monitor blood pressure, and deliver fluids or contrast up to 300 psi.
Definition and scope
The BD Nexiva closed IV catheter system is an integrated peripheral vascular access device manufactured by Becton Dickinson Infusion Therapy Systems Inc. In traditional practice, peripheral venous cannulation requires clinicians to place an open catheter, withdraw the needle, compress the vein manually to stem blood leakage, and attach separate extension sets and stabilization devices. The BD Nexiva combines all four components into a single pre-assembled sterile device: a radiopaque cannula, an automated needle shield, built-in stabilization wings, and integrated extension tubing with a clamp and needle-free access port.
In the United States, the BD Nexiva family is regulated by the FDA as a Class II medical device under 21 CFR 880.5200 (Intravascular catheter, product code FOZ). Documented across 13 clearances in the openFDA database—from original clearance K032843 in 2004 to clearance K243403 in July 2025—it is indicated for short-term peripheral access (under 30 days) to sample blood, monitor blood pressure, and administer intravenous fluids or medications. The device conforms to international consensus standards including ISO 80369-7 for Luer connectors and ISO 11607-1 for sterile barrier packaging, alongside verified testing for kink resistance and blood fill time.
How it works or how it is used in practice
The engineering of the BD Nexiva system addresses primary causes of catheter failure in peripheral IV catheters, focusing on biomaterial behavior, venipuncture feedback, and sharps containment.
A central feature is BD Vialon™ biomaterial, a specialized polyurethane that softens up to 70% in vivo at physiological temperature. While rigid during insertion to facilitate smooth skin penetration, the cannula becomes pliable within the vessel lumen. This flexibility minimizes mechanical irritation against the vascular endothelium, significantly reducing mechanical phlebitis while maintaining elastomeric memory to recover from transient kinking.
To confirm successful cannulation, BD Instaflash™ needle technology incorporates a laser-cut micro-notch near the needle tip. As soon as the bevel enters the vein lumen, blood immediately enters the notch and appears between the clear cannula and needle shaft. This immediate primary flashback verifies placement before secondary blood flow reaches the extension line, reducing posterior vein wall punctures in fragile vessels.
Occupational protection is maintained by passive needle shielding and closed fluid containment. Upon needle withdrawal from the hub, a protective shield automatically encapsulates the needle point permanently without requiring manual button activation. Concurrently, an internal septum and sealed extension line contain blood within the device, eliminating blood splash and manual vein occlusion.
Types or related concepts
The BD Nexiva family encompasses single-port and dual-port configurations across standardized clinical sizes, representing a key advancement in closed IV catheter systems.
- Single Port: Integrates a single extension line with a slide clamp, available with a Luer lock or pre-attached BD MaxZero™ connector for routine fluid infusion and intermittent blood sampling.
- Dual Port: Integrates a Y-shaped extension set with two independent ports using BD Q-Syte™ or BD MaxZero™ needleless connectors, enabling simultaneous infusions or line flushes without disconnecting running fluids.
The table below summarizes technical characteristics across catheter types, verified against FDA clearances and manufacturer technical documentation:
| System Category | Catheter Biomaterial | Flashback Confirmation | Needle Safety Type | Venous Blood Containment | Max Power Injection Rating |
|---|---|---|---|---|---|
| Traditional Open PIVC | Standard FEP or Polyurethane | Rear hub flash chamber only | Manual shield or active push-button | Open hub (requires manual venous occlusion) | Varies (many unrated or limited to 50 psi) |
| BD Nexiva Closed System | BD Vialon Polyurethane (thermosoftening) | BD Instaflash (notch) plus extension tube flash | Passive automatic encapsulation | Fully closed pre-assembled extension line | 300 psi (18–22 GA devices; 24 GA excluded) |
| BD Nexiva Diffusics | BD Vialon Polyurethane (diffusing tip) | BD Instaflash (notch) plus extension tube flash | Passive automatic encapsulation | Fully closed pre-assembled extension line | 325 psi (with multi-bore diffusion nozzle) |
Diameters span 18 GA (green), 20 GA (pink), 22 GA (blue), and 24 GA (yellow) with lengths from 0.56 to 1.75 inches, selected according to clinical catheter gauge selection guidelines for vein caliber and fluid delivery rates.
Where it matters for labs, clinics or supply decisions
Deploying closed IV catheter systems influences clinical safety, radiology protocols, and laboratory specimen integrity:
Occupational Safety and Infection Control: Closed blood containment eliminates blood leakage during cannulation, reducing biohazard exposure and supporting institutional compliance with OSHA bloodborne pathogen standards.
Stabilization and Dwell Times: Built-in stabilization wings seat flat beneath a transparent IV dressing. Because infusions connect at the distal extension tubing rather than directly at the catheter hub, mechanical torquing on the cannula is minimized, reducing micro-motion, phlebitis, and premature restart rates.
Radiology Power Injection Protocols: FDA 510(k) clearance K243403 confirms that 18 GA, 20 GA, and 22 GA Nexiva catheters withstand power injection up to 300 psi (2,068 kPa). This compatibility allows clinical teams to perform contrast-enhanced computed tomography (CT) scans through existing lines without placing dedicated high-pressure access.
Clinical Research Specimen Collection: In pharmacology research and clinical trials, the closed line facilitates blood sampling without breaking sterile fluid connections or introducing stopcocks that cause hemolysis.
Common misunderstandings
- Misunderstanding: All BD Nexiva sizes can be used for power injection. Fact: Only 18 GA, 20 GA, and 22 GA catheters are rated up to 300 psi. The 24 GA catheter (yellow platform) is contraindicated for power injectors due to high fluid resistance in smaller lumens.
- Misunderstanding: Adding an extension set to an open catheter creates a closed system. Fact: Bedside modular assemblies leave the catheter hub open during cannulation, failing to provide the blood containment and passive needle shielding of an integrated device.
- Misunderstanding: Power injection can be run through any attached port. Fact: FDA labeling requires that any access port or needle-free connector not explicitly rated for 300 psi must be removed prior to high-pressure contrast injection.
- Misunderstanding: Thermosoftening material collapses during blood draws. Fact: BD Vialon softens to reduce endothelial shear while maintaining radial lumen integrity, preventing collapse during syringe aspiration.
Frequently asked questions
What is the BD Nexiva closed IV catheter system?
The BD Nexiva closed IV catheter is an integrated peripheral catheter combining a radiopaque cannula, passive needle shield, stabilization platform, and extension set with needle-free ports into a single sterile unit cleared under FDA 21 CFR 880.5200.
Can BD Nexiva catheters be used for power injection?
Yes. BD Nexiva catheters in sizes 18 GA, 20 GA, and 22 GA are FDA-cleared for power injection of contrast media up to 300 psi (2,068 kPa) when non-power-rated access ports are removed. The 24 GA size is not rated for power injection.
How does BD Instaflash needle technology work?
BD Instaflash technology uses a micro-notch near the needle point. Upon entering the vessel, blood enters the notch immediately, producing visible blood return between the cannula and needle shaft before secondary flow reaches the extension line.
Why does BD Nexiva reduce blood exposure compared to open catheters?
Open catheters expose the venous lumen upon needle retraction, requiring manual compression. BD Nexiva features an internal septum and pre-attached extension tubing that seal blood inside the catheter throughout cannulation.
Sources
- U.S. Food and Drug Administration (FDA), 510(k) Premarket Notification K243403, BD Nexiva Closed IV Catheter System (cleared July 25, 2025): https://www.accessdata.fda.gov/cdrh_docs/pdf24/K243403.pdf (read 2026-11-11).
- openFDA Medical Device Classification and Global Unique Device Identification Database (GUDID), 21 CFR 880.5200 / Product Code FOZ: https://api.fda.gov/device/510k.json (read 2026-11-11).
- Becton, Dickinson and Company (BD), BD Nexiva Closed IV Catheter System Technical and Clinical Overview: https://www.bd.com/en-us/products-and-solutions/products/product-families/bd-nexiva-closed-iv-catheter-system (read 2026-11-11).
